期刊文献+

100例乙型肝炎病毒携带者乙型肝炎疫苗接种相关知识的抽样调查 被引量:1

The sample Investigation about the knowledge of HBV vacdne from 100 carriers of HBV
下载PDF
导出
摘要 目的 通过对乙型肝炎病毒携带者有关乙型肝炎疫苗接种等知识的抽样调查,以了解特定人群相关卫生知识普及程度。方法 随机抽取乙型肝炎病毒携带者100例,针对乙型肝炎疫苗接种的相关知识进行问卷调查。结果除最常见的传播途经外,消化道传播似也有可能;多数人不知道乙型肝炎的发展结局,因此,他们往往忽视治疗。结论目前预防乙型肝炎最有效的方法仍然是接受乙型肝炎疫苗注射;定期接种乙型肝炎疫苗,对本人、家庭和社会都有重要的现实意义;正确的心理引导,可提高患者对疾病治疗的信心,增加免疫力,是乙型肝炎治疗必不可少的方法之一。 Objective By sample study,we confirm that the vaccination of HBV should be compulsory to the civil vaccine plan. Method Making a sample research from 100 camera of HBV, we aim at the knowledge of HBV vaccine by using the surveying answer sheets. Results Apart from the regular transmittal method, the feces-oral access has been mostly concemed about. Moreover, as they don't know the final result of the disease and may have financial difficulty,they often tend to ignore and give up the treatment. And it leads to a serious ending at last. Conclusion The most efficient method to prevent hepatitis B has been the injection of HBV vaccine recently.The right psychological leading not only could increase the confidence of their treatment and the ability of their immunization, but also in an essential method of treatment of the hepatitis B.
出处 《实用肝脏病杂志》 CAS 2003年第4期202-204,共3页 Journal of Practical Hepatology
关键词 乙型肝炎病毒携带者 预防接种 Hepatitis B viral carrier Preventive vaccination
  • 相关文献

参考文献1

二级参考文献7

  • 1戴志澄 祁国明 等.乙肝病毒性肝炎的流行特征,中国病毒性肝炎血清流行病学调查1992-1995[M].北京:科学技术文献出版社,1997.39-59.
  • 2Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol, 1993,4:273-283.
  • 3Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. NEJM, 1998,339:61-68.
  • 4Kobayashi Satsuki, Ide Tatsuya, Sata Miehio, et al. Detection of YMDD motif mutations in some lamivudine~untreated asymptomatic hepatitis B virus carriers. J Hepatol, 2001,34 : 584-586.
  • 5Kirishima Toshihiko, Okanoue Takeshi, Daimon Yukiko, et al.Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J Hepatol, 2002, 37: 259-265.
  • 6拉米夫定临床应用专家指导小组.2000年拉米夫定临床应用指导意见[J].中华肝脏病杂志,2000,8(4):249-250. 被引量:114
  • 7拉米夫定临床应用专家指导小组.2001年拉米夫定临床应用专家共识[J].中华肝脏病杂志,2002,10(2):157-158. 被引量:71

共引文献118

同被引文献2

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部